BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet

  December 29, 2025

   · 

  4 min read
• Press Releases

  Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

  December 29, 2025

   · 

  4 min read
• Press Releases

  CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

  December 29, 2025

   · 

  4 min read
• Press Releases

  Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

  December 29, 2025

   · 

  21 min read
• Press Releases

  Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  December 29, 2025

   · 

  10 min read
• Press Releases

  neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)

  December 29, 2025

   · 

  11 min read
• Press Releases

  Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

  December 29, 2025

   · 

  8 min read
• Press Releases

  60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State

  December 29, 2025

   · 

  7 min read
• Press Releases

  Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

  December 29, 2025

   · 

  5 min read
• Press Releases

  Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA

  December 29, 2025

   · 

  5 min read